ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Vyndaqel®, Weichkapseln:Pfizer AG
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Zusammensetzung

Wirkstoffe
Weichkapseln zu 20 mg: Tafamidisum megluminum.
Weichkapseln zu 61 mg: Tafamidisum.
Hilfsstoffe
Weichkapsel zu 20 mg: Brilliantblau FCF, carminum, gelatina, glycerolum, ferrum oxydatum flavum, macrogolum 400, polysorbatum 80, polyvinylis acetas phthalas, propylenglycolum, sorbitani mono-oleas, sorbitolum liquidum partim deshydricum corresp. sorbitolum (E 420, max. 44 mg), titanii dioxidum.
Weichkapsel zu 61 mg: Butylhydroxytoluenum, gelatina, glycerolum, ferrum oxydatum rubrum, macrogolum 400, polysorbatum 20, polyvinylis acetas phthalas, povidonum (K-Wert 90), propylenglycolum, sorbitolum liquidum partim deshydricum corresp. sorbitolum (E 420, max. 44 mg), titanii dioxidum.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home